BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29688733)

  • 21. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006.
    Sepehri G; Talebizadeh N; Mirzazadeh A; Mohsenbeigi M
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):180-5. PubMed ID: 18001003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].
    Philippe F; Cambou JP; Danchin N; Thomas D
    Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S30-6. PubMed ID: 16411649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 26. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of antihypertensive therapy among ischemic stroke survivors: impact of ischemic heart disease.
    Hassan Y; Aziz NA; Al-Jabi SW; Looi I; Zyoud SH
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):282-8. PubMed ID: 20472813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?
    Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I
    PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
    Barski L; Porath A; Novack V; Jotkowitz A
    Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes.
    Yu AY; Keezer MR; Zhu B; Wolfson C; Côté R
    Cerebrovasc Dis; 2009; 27(4):398-402. PubMed ID: 19276623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study.
    Pilmore HL; Skeans MA; Snyder JJ; Israni AK; Kasiske BL
    Transplantation; 2011 Mar; 91(5):542-51. PubMed ID: 21301401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Under-prescribing of cardiovascular therapies for diabetes in primary care.
    Bennett KE; Williams D; Feely J
    Eur J Clin Pharmacol; 2003 Apr; 58(12):835-41. PubMed ID: 12698311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
    Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG
    Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
    Feher G; Koltai K; Papp E; Alkonyi B; Solyom A; Kenyeres P; Kesmarky G; Czopf L; Toth K
    Drugs Aging; 2006; 23(7):559-67. PubMed ID: 16930084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study.
    Gupta R; Islam S; Mony P; Kutty VR; Mohan V; Kumar R; Thakur JS; Shankar VK; Mohan D; Vijayakumar K; Rahman O; Yusuf R; Iqbal R; Shahid M; Mohan I; Rangarajan S; Teo KK; Yusuf S
    Eur J Prev Cardiol; 2015 Oct; 22(10):1261-71. PubMed ID: 24942224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.